Literature DB >> 33621954

Raddeanin A inhibits proliferation, invasion, migration and promotes apoptosis of cervical cancer cells via regulating miR-224-3p/Slit2/Robo1 signaling pathway.

Xin Shen1, Lingxia Li2, Yuanyuan He2, Xiaohui Lv2, Jiajia Ma2.   

Abstract

Raddeanin A (RA), an active triterpenoid saponin extracted from the Anemone raddeana regel, plays an essential role in the suppression of many malignancies. We aimed to investigate the effects and potential mechanisms of RA on cervical cancer (CC). RA was used to treat CC cell lines (Hela and c-33A) for 24 h and 48 h. Then, the invasion, migration and cell cycle distribution of these two cell lines with RA treatment were respectively detected by transwell, wound healing and flow cytometry. Results revealed that RA significantly inhibited the invasion, migration, promoted the cell cycle arrest and apoptosis of Hela and c-33A cells. Moreover, RA was confirmed to activate the Slit2/Robo1 signaling, and bioinformatics analysis and luciferase reporter assay verified that miR-224-3p could target Slit2. Additionally, miR-224-3p overexpression reversed the inhibitory effect of RA on invasion and migration of CC cells, and it also restored the promoting effects of RA on cell cycle arrest and apoptosis. Lastly, miR-224-3p-upregulation inactivated the expression of Slit2 and Robo1 in RA-treated Hela and c-33A cells. These findings demonstrated that RA inhibits proliferation, invasion, migration and promotes apoptosis of CC cells through miR-224-3p/Slit2/Robo1 signaling pathway, which might guide the future studies or treatment of this disease.

Entities:  

Keywords:  Raddeanin A; cervical cancer; invasion; migration; proliferation

Mesh:

Substances:

Year:  2021        PMID: 33621954      PMCID: PMC7993697          DOI: 10.18632/aging.202574

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  33 in total

Review 1.  Moving away from the midline: new developments for Slit and Robo.

Authors:  Athena R Ypsilanti; Yvrick Zagar; Alain Chédotal
Journal:  Development       Date:  2010-06       Impact factor: 6.868

Review 2.  Immunotherapy and targeted therapy for cervical cancer: an update.

Authors:  Gulden Menderes; Jonathan Black; Carlton L Schwab; Alessandro D Santin
Journal:  Expert Rev Anticancer Ther       Date:  2015-12-07       Impact factor: 4.512

3.  Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy.

Authors:  Eva Johanna Kantelhardt; Ulrike Moelle; Matthias Begoihn; Adamu Addissie; Pietro Trocchi; Bekuretsion Yonas; Petros Hezkiel; Andreas Stang; Christoph Thomssen; Dirk Vordermark; Tufa Gemechu; Yirgu Gebrehiwot; Tigeneh Wondemagegnehu; Abreha Aynalem; Assefa Mathewos
Journal:  Oncologist       Date:  2014-06-20

Review 4.  [Research progress of miRNAs targeting GSK-3β in regulation of hepatocellular carcinoma invasion and metastasis].

Authors:  Song-Qi He; Bin Wen; Guan-Xin Chen; Hai-Tao Sun; Jia-Ling Sun; Xue-Mei Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

5.  Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.

Authors:  Yu Wang; Xiaowen Bao; Ang Zhao; Jie Zhang; Mingya Zhang; Qi Zhang; Bo Ma
Journal:  Life Sci       Date:  2018-07-01       Impact factor: 5.037

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 7.  The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system.

Authors:  Rachel E Dickinson; W Colin Duncan
Journal:  Reproduction       Date:  2010-01-25       Impact factor: 3.906

8.  Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significances.

Authors:  Sraboni Mitra; Dipanjana Mazumder-Indra; Ranajit K Mondal; Partha S Basu; Anup Roy; Susanta Roychoudhury; Chinmay K Panda
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

9.  Autophagy Protects from Raddeanin A-Induced Apoptosis in SGC-7901 Human Gastric Cancer Cells.

Authors:  Yu-Hao Teng; Jie-Pin Li; Shen-Lin Liu; Xi Zou; Liang-Hua Fang; Jin-Yong Zhou; Jian Wu; Song-Yang Xi; Yan Chen; Ying-Ying Zhang; Song Xu; Rui-Ping Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-15       Impact factor: 2.629

10.  Raddeanin A Induces Apoptosis and Cycle Arrest in Human HCT116 Cells through PI3K/AKT Pathway Regulation In Vitro and In Vivo.

Authors:  Chunqin Meng; Yuhao Teng; Xiaodong Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-26       Impact factor: 2.629

View more
  4 in total

1.  SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm.

Authors:  Ting-Juan Zhang; Zi-Jun Xu; Xiang-Mei Wen; Yu Gu; Ji-Chun Ma; Qian Yuan; Jiang Lin; Jing-Dong Zhou; Jun Qian
Journal:  Leukemia       Date:  2022-07-29       Impact factor: 12.883

2.  Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.

Authors:  Angelina Huseinovic; Annelieke Jaspers; Annina P van Splunter; Hanne Sørgård; Saskia M Wilting; Dorian R A Swarts; Ida H van der Meulen; Victor W van Beusechem; Renée X de Menezes; Renske D M Steenbergen
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  1α,25(OH)2D3(VD3) promotes Raddeanin A-induced anti-proliferative effects on HeLa cell apoptosis and autophagy through negative regulation of HPV18E6-E7/PD-L1/VDR axis.

Authors:  Zhiyu Li; Biyun Xu; Yuexin Sun; Lanbo Zhou; Yue Tao; Wenjun Hou; Jun Bao; Jun Liu; Weixin Fan
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

4.  Tetramethylpyrazine inhibits the proliferation, invasiveness and migration of cervical cancer C33A cells by retarding the Hedgehog signaling pathway.

Authors:  Jing Ren; Jiping Cai; Changfeng Wang
Journal:  Oncol Lett       Date:  2022-01-03       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.